PathAI Company
PathAI’s services solve challenging pathology problems faced by the research and pharmaceutical industry. The PathAI platform provides end-to-end automation for reliable, scalable, and cost-effective long-term solutions. PathAI is developing technology that assists pathologists in making rapid and accurate diagnoses for every patient, every time. The company was founded in 2016 and based in Boston, Massachusetts.
Investors
Technology:
Others
Industry:
Clinical Development
Headquarters:
Boston, Massachusetts, United States
Founded Date:
2016-01-01
Employees Number:
101-250
Funding Status:
Late Stage Venture
Investors Number:
18
Total Funding:
255200000
Estimated Revenue:
$10M to $50M
Last Funding Date:
2021-05-18
Last Funding Type:
Series C
Register and Claim Ownership